Cover Syl Tab
Dxn presentation
Ventricular septal defect, congenital heart disease
Dr. harman vasopeptidase inhibition
Summary of NKF-KDOQI guideline on Diabetes and CKD
Role of raas inhibition in management of hypertension
Fibrillation Auriculaire: Thérapies en Amont Fibrillation Auriculaire: Thérapies en Amont Gerald V. Naccarelli M.D. Research support: Boston-Scientific,
Sharma Prabhakar MD MBA FACP FASN Professor and Chief, Nephrology Division Texas Tech University Health Sciences Center “Angiotensin-Insulin Cross Talk”
On behalf of the CHARM Programme Investigators and Committees Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity CHARM.
E. Gronda, MD, FESC Cardiology Division Cardiovascular Department IRCCS, H S. Giuseppe, MultiMedica, Group S.S. Giovanni - Milano “Can Neurohormonal Antagonists.
The Challenges and Opportunities of AHSCs King’s College London March 6, 2009 Victor J Dzau, MD James B Duke Professor of Medicine Chancellor for Health.
ASTORASTOR Alport Syndrome Treatments and Outcomes Registry Alport Syndrome Family Conference Alport Syndrome Registries Clifford E. Kashtan, M.D. University.
